Lyman SD - Search Results

1

The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro.

Rusten LS, Lyman SD, Veiby OP, Jacobsen SE. Rusten LS, et al. Among authors: lyman sd. Blood. 1996 Feb 15;87(4):1317-25. Blood. 1996. PMID: 8608220 Free article.

2

Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha.

Jacobsen SE, Veiby OP, Myklebust J, Okkenhaug C, Lyman SD. Jacobsen SE, et al. Among authors: lyman sd. Blood. 1996 Jun 15;87(12):5016-26. Blood. 1996. PMID: 8652814 Free article.

3

Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells.

Veiby OP, Lyman SD, Jacobsen SE. Veiby OP, et al. Among authors: lyman sd. Blood. 1996 Aug 15;88(4):1256-65. Blood. 1996. PMID: 8695843 Free article.

4

Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3.

Ramsfjell V, Borge OJ, Veiby OP, Cardier J, Murphy MJ Jr, Lyman SD, Lok S, Jacobsen SE. Ramsfjell V, et al. Among authors: lyman sd. Blood. 1996 Dec 15;88(12):4481-92. Blood. 1996. PMID: 8977240 Free article.

5

Bidirectional effect of interleukin-10 on early murine B-cell development: stimulation of flt3-ligand plus interleukin-7-dependent generation of CD19(-) ProB cells from uncommitted bone marrow progenitor cells and growth inhibition of CD19(+) ProB cells.

Veiby OP, Borge OJ, Mârtensson A, Beck EX, Schade AE, Grzegorzewski K, Lyman SD, Mârtensson IL, Jacobsen SE. Veiby OP, et al. Among authors: lyman sd. Blood. 1997 Dec 1;90(11):4321-31. Blood. 1997. PMID: 9373243 Free article.

6

c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities.

Lyman SD, Jacobsen SE. Lyman SD, et al. Blood. 1998 Feb 15;91(4):1101-34. Blood. 1998. PMID: 9454740 Free article. Review. No abstract available.

7

The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors.

Jacobsen SE, Okkenhaug C, Myklebust J, Veiby OP, Lyman SD. Jacobsen SE, et al. Among authors: lyman sd. J Exp Med. 1995 Apr 1;181(4):1357-63. doi: 10.1084/jem.181.4.1357. J Exp Med. 1995. PMID: 7535335 Free PMC article.

8

The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.

Veiby OP, Jacobsen FW, Cui L, Lyman SD, Jacobsen SE. Veiby OP, et al. Among authors: lyman sd. J Immunol. 1996 Oct 1;157(7):2953-60. J Immunol. 1996. PMID: 8816402

9

Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells.

McKenna HJ, de Vries P, Brasel K, Lyman SD, Williams DE. McKenna HJ, et al. Among authors: lyman sd. Blood. 1995 Nov 1;86(9):3413-20. Blood. 1995. PMID: 7579445 Free article.

10

flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions.

Strobl H, Bello-Fernandez C, Riedl E, Pickl WF, Majdic O, Lyman SD, Knapp W. Strobl H, et al. Among authors: lyman sd. Blood. 1997 Aug 15;90(4):1425-34. Blood. 1997. PMID: 9269760 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page